These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 23357311

  • 1. Introducing new dimensions in MIA-QSAR: a case for chemokine receptor inhibitors.
    Nunes CA, Freitas MP.
    Eur J Med Chem; 2013 Apr; 62():297-300. PubMed ID: 23357311
    [Abstract] [Full Text] [Related]

  • 2. MIA-QSAR evaluation of a series of sulfonylurea herbicides.
    Bitencourt M, Freitas MP.
    Pest Manag Sci; 2008 Aug; 64(8):800-7. PubMed ID: 18338340
    [Abstract] [Full Text] [Related]

  • 3. aug-MIA-QSAR modeling of antimicrobial activities and design of multi-target anilide derivatives.
    Nunes CA, Freitas MP.
    J Microbiol Methods; 2013 Sep; 94(3):217-20. PubMed ID: 23831437
    [Abstract] [Full Text] [Related]

  • 4. Prediction of 13C chemical shifts in methoxyflavonol derivatives using MIA-QSPR.
    Goodarzi M, Freitas MP, Ramalho TC.
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct 01; 74(2):563-8. PubMed ID: 19648055
    [Abstract] [Full Text] [Related]

  • 5. The MIA-QSAR method for the prediction of bioactivities of possible acetylcholinesterase inhibitors.
    Bitencourt M, Freitas MP, Rittner R.
    Arch Pharm (Weinheim); 2012 Sep 01; 345(9):723-8. PubMed ID: 22674790
    [Abstract] [Full Text] [Related]

  • 6. Exploring MIA-QSARs' for antimalarial quinolon-4(1H)-imines.
    Duarte MH, Barigye SJ, Freitas MP.
    Comb Chem High Throughput Screen; 2015 Sep 01; 18(2):208-16. PubMed ID: 25543687
    [Abstract] [Full Text] [Related]

  • 7. MIA-QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA-ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives.
    Goodarzi M, Freitas MP.
    Eur J Med Chem; 2010 Apr 01; 45(4):1352-8. PubMed ID: 20060625
    [Abstract] [Full Text] [Related]

  • 8. 3D perspective into MIA-QSAR: A case for anti-HCV agents.
    Daré JK, Ramalho TC, Freitas MP.
    Chem Biol Drug Des; 2019 Jun 01; 93(6):1096-1104. PubMed ID: 30411494
    [Abstract] [Full Text] [Related]

  • 9. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
    Marrero-Ponce Y.
    J Chem Inf Comput Sci; 2004 Jun 01; 44(6):2010-26. PubMed ID: 15554670
    [Abstract] [Full Text] [Related]

  • 10. Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR.
    Antunes JE, Freitas MP, Rittner R.
    Eur J Med Chem; 2008 Aug 01; 43(8):1632-8. PubMed ID: 18045743
    [Abstract] [Full Text] [Related]

  • 11. 4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors.
    Ma W, Wang Y, Chu D, Yan H.
    J Mol Graph Model; 2019 Nov 01; 92():357-362. PubMed ID: 31450065
    [Abstract] [Full Text] [Related]

  • 12. Is molecular alignment an indispensable requirement in the MIA-QSAR method?
    Barigye SJ, Freitas MP.
    J Comput Chem; 2015 Sep 05; 36(23):1748-55. PubMed ID: 26119527
    [Abstract] [Full Text] [Related]

  • 13. Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.
    Daré JK, Silva DR, Ramalho TC, Freitas MP.
    Mol Simul; 2020 Aug 04; 46(14):1055-1061. PubMed ID: 34191894
    [Abstract] [Full Text] [Related]

  • 14. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S, Hamzeh-Mivehroud M, Ghafourian T, Hamzeiy H.
    J Mol Graph Model; 2008 Jan 04; 26(5):834-44. PubMed ID: 17561422
    [Abstract] [Full Text] [Related]

  • 15. Bi- and multilinear PLS coupled to MIA-QSAR in the prediction of antifungal activities of some benzothiazole derivatives.
    Bitencourt M, Freitas MP.
    Med Chem; 2009 Jan 04; 5(1):79-86. PubMed ID: 19149653
    [Abstract] [Full Text] [Related]

  • 16. Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors.
    Muthukumaran P, Rajiniraja M.
    J Theor Biol; 2019 May 21; 469():18-24. PubMed ID: 30826336
    [Abstract] [Full Text] [Related]

  • 17. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA, Goodarzi M, Freitas MP.
    Chem Biol Drug Des; 2009 Feb 21; 73(2):244-52. PubMed ID: 19207427
    [Abstract] [Full Text] [Related]

  • 18. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
    Zhuo Y, Kong R, Cong XJ, Chen WZ, Wang CX.
    Eur J Med Chem; 2008 Dec 21; 43(12):2724-34. PubMed ID: 18538451
    [Abstract] [Full Text] [Related]

  • 19. Predicting boiling points of aliphatic alcohols through multivariate image analysis applied to quantitative structure-property relationships.
    Goodarzi M, Freitas MP.
    J Phys Chem A; 2008 Nov 06; 112(44):11263-5. PubMed ID: 18841953
    [Abstract] [Full Text] [Related]

  • 20. QSAR modeling using chirality descriptors derived from molecular topology.
    Golbraikh A, Tropsha A.
    J Chem Inf Comput Sci; 2003 Nov 06; 43(1):144-54. PubMed ID: 12546547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.